234 related articles for article (PubMed ID: 23539188)
1. The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid.
Westerhout J; Smeets J; Danhof M; de Lange EC
J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):327-42. PubMed ID: 23539188
[TBL] [Abstract][Full Text] [Related]
2. Prediction of methotrexate CNS distribution in different species - influence of disease conditions.
Westerhout J; van den Berg DJ; Hartman R; Danhof M; de Lange EC
Eur J Pharm Sci; 2014 Jun; 57():11-24. PubMed ID: 24462766
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures.
Venkatakrishnan K; Tseng E; Nelson FR; Rollema H; French JL; Kaplan IV; Horner WE; Gibbs MA
Drug Metab Dispos; 2007 Aug; 35(8):1341-9. PubMed ID: 17470526
[TBL] [Abstract][Full Text] [Related]
4. Impact of P-Glycoprotein-Mediated Active Efflux on Drug Distribution into Lumbar Cerebrospinal Fluid in Nonhuman Primates.
Nagaya Y; Katayama K; Kusuhara H; Nozaki Y
Drug Metab Dispos; 2020 Nov; 48(11):1183-1190. PubMed ID: 32862147
[TBL] [Abstract][Full Text] [Related]
5. Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain.
Kervezee L; Hartman R; van den Berg DJ; Shimizu S; Emoto-Yamamoto Y; Meijer JH; de Lange EC
AAPS J; 2014 Sep; 16(5):1029-37. PubMed ID: 24917180
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats.
Durk MR; Fan J; Sun H; Yang Y; Pang H; Pang KS; de Lannoy IA
Pharm Res; 2015 Mar; 32(3):1128-40. PubMed ID: 25319098
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates.
Braun C; Sakamoto A; Fuchs H; Ishiguro N; Suzuki S; Cui Y; Klinder K; Watanabe M; Terasaki T; Sauer A
Mol Pharm; 2017 Oct; 14(10):3436-3447. PubMed ID: 28880093
[TBL] [Abstract][Full Text] [Related]
9. Estimation of the unbound brain concentration of P-glycoprotein substrates or nonsubstrates by a serial cerebrospinal fluid sampling technique in rats.
Mariappan TT; Kurawattimath V; Gautam SS; Kulkarni CP; Kallem R; Taskar KS; Marathe PH; Mandlekar S
Mol Pharm; 2014 Feb; 11(2):477-85. PubMed ID: 24380373
[TBL] [Abstract][Full Text] [Related]
10. Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(-/-) rats.
Nagaya Y; Nozaki Y; Takenaka O; Watari R; Kusano K; Yoshimura T; Kusuhara H
Drug Metab Pharmacokinet; 2016 Feb; 31(1):57-66. PubMed ID: 26830080
[TBL] [Abstract][Full Text] [Related]
11. Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainate.
Syvänen S; Schenke M; van den Berg DJ; Voskuyl RA; de Lange EC
AAPS J; 2012 Mar; 14(1):87-96. PubMed ID: 22215264
[TBL] [Abstract][Full Text] [Related]
12. Utility of cerebrospinal fluid drug concentration as a surrogate for unbound brain concentration in nonhuman primates.
Nagaya Y; Nozaki Y; Kobayashi K; Takenaka O; Nakatani Y; Kusano K; Yoshimura T; Kusuhara H
Drug Metab Pharmacokinet; 2014; 29(5):419-26. PubMed ID: 24806821
[TBL] [Abstract][Full Text] [Related]
13. Quantitative investigation of the brain-to-cerebrospinal fluid unbound drug concentration ratio under steady-state conditions in rats using a pharmacokinetic model and scaling factors for active efflux transporters.
Kodaira H; Kusuhara H; Fuse E; Ushiki J; Sugiyama Y
Drug Metab Dispos; 2014 Jun; 42(6):983-9. PubMed ID: 24644297
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein protein expression versus functionality at the blood-brain barrier using immunohistochemistry, microdialysis and mathematical modeling.
De Lange ECM; Vd Berg DJ; Bellanti F; Voskuyl RA; Syvänen S
Eur J Pharm Sci; 2018 Nov; 124():61-70. PubMed ID: 30144528
[TBL] [Abstract][Full Text] [Related]
15. Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice.
Saleh MAA; Gülave B; Campagne O; Stewart CF; Elassaiss-Schaap J; de Lange ECM
Pharm Res; 2023 Nov; 40(11):2555-2566. PubMed ID: 37442882
[TBL] [Abstract][Full Text] [Related]
16. In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study.
Chan GN; Saldivia V; Yang Y; Pang H; de Lannoy I; Bendayan R
J Neurochem; 2013 Nov; 127(3):342-52. PubMed ID: 23777437
[TBL] [Abstract][Full Text] [Related]
17. Utility of CSF in translational neuroscience.
de Lange EC
J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):315-26. PubMed ID: 23400635
[TBL] [Abstract][Full Text] [Related]
18. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat.
Shimizu S; den Hoedt SM; Mangas-Sanjuan V; Cristea S; Geuer JK; van den Berg DJ; Hartman R; Bellanti F; de Lange EC
Drug Metab Dispos; 2017 Feb; 45(2):152-159. PubMed ID: 27836941
[TBL] [Abstract][Full Text] [Related]
19. Interaction between topically and systemically coadministered P-glycoprotein substrates/inhibitors: effect on vitreal kinetics.
Hippalgaonkar K; Srirangam R; Avula B; Khan IA; Majumdar S
Drug Metab Dispos; 2010 Oct; 38(10):1790-7. PubMed ID: 20595378
[TBL] [Abstract][Full Text] [Related]
20. Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain.
Sun H; Bungay PM; Elmquist WF
J Pharmacol Exp Ther; 2001 Jun; 297(3):991-1000. PubMed ID: 11356921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
